VR Adviser »

Research Alliance Corp Iii shares owned by VR Adviser

Quarter-by-quarter ownership of Research Alliance Corp Iii shares owned by VR Adviser from 13F filings

Historical chart of VR Adviser investment in Research Alliance Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Research Alliance Corp Iii held by VR Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Research Alliance Corp Iii by VR Adviser

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.2M 300k 10.70

More positions owned by VR Adviser

Apogee Therapeutics (APGE)
Oruka Therapeutics (ORKA)
Erasca (ERAS)
Spyre Therapeutics Com New (SYRE)
Dianthus Therapeutics (DNTH)
Ocular Therapeutix (OCUL)
Damora Therapeutics Com New (DMRA)
Savara (SVRA)
Jade Biosciences Com New (JBIO)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Vor Biopharma Com New (VOR)
Dyne Therapeutics (DYN)
Maze Therapeatics (MAZE)
Relmada Therapeutics (RLMD)

View all positions for VR Adviser

Top funds holding Research Alliance Corp Iii

Perceptive Advisors
ADAR1 Capital Management
BVF
Balyasny Asset Management
Spruce Street Capital
Trails Edge Capital Partners
TCG Crossover Management
Commodore Capital
Jupiter Topco
Braidwell
Cormorant Asset Management
Affinity Asset Advisors
Silverarc Capital Management
VR Adviser
J. Goldman & Co

View all funds holding Research Alliance Corp Iii